26.11.2020
Artur Isaev, the founder of the Human Stem Cells Institute (HSCI), bought out a 17.79% share of Russian Venture Company's (RVC's) biofund in the HSCI portfolio company, the Genetico laboratory network. The details of the transaction were not disclosed; it is known, however, that the biofund has invested about 180 million roubles since 2014, and the transaction was profitable for RVC, the Company said.